MMikrobiomik Healthcare Company — Seed (estimated) · €1M
A €1M capital increase was fully subscribed by the founding and existing partners to cover the regulatory costs of bringing MBK-01 to market. It was announced alongside the launch of a €6-10M strategic round advised by CaixaBank CIB. That larger round has no reported close.
Lead unknown
RoundSeed (estimated)
AnnouncedMar 2024
CityDerio
SectorHealthtech & Bio · Biotech / Microbiome therapeutics
Source
A
The company
Investors
No investors were disclosed for this round.